Journal of Industrial Convergence (산업융합연구)

DAEHAN Society of Industrial Management (대한산업경영학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Nurse-led Patient Education for Gout Patients

통풍환자에 대한 간호사 주도 환자교육의 효과

  • Yoo, Inseol (Division of Rheumatology, Department of Internal Medicine, Chungnam National University Sejong Hospital) ;
  • Jung, Sunkyung (Chungnam National University Sejong Hospital)
  • 유인설 (세종충남대학교병원 류마티스내과) ;
  • 정선경 (세종충남대학교병원 미래의학연구원)
  • Received : 2022.05.27
  • Accepted : 2022.07.20
  • Published : 2022.07.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was performed to analyze the effect of nurse-led education on results for patients with gout. Methods: The face-to-face education was conducted by a specialist nurse. Patient satisfaction and drug adherence, serum uric acid was assessed. Results: Patient satisfaction was significantly higher in the nurse-led education group than in the usual care group. The serum uric acid level on the second visit was lower after patient education. In addition, the mean drug adherence in the nurse-led group was significantly higher than in the usual care group on the second and third visits. Conclusion: The nurse-led education about gout improves patient satisfaction, drug adherence, and serum uric acid level in patients with gout.

통풍은 관절염뿐만 아니라 심혈관질환 등을 유발하는 만성염증질환이다. 하지만 대부분의 환자들이 단순히 관절질환으로 인식하고 있어 치료에 장애로 작용한다. 이 연구를 통해 간호사 주도의 통풍환자 대상 교육이 환자의 통풍에 대한 인식 개선 및 질병 경과에 미치는 영향을 확인하고자 하였다. 교육전문 간호사가 상급종합병원 류마티스내과 외래에 내원한 환자를 대상으로 통풍에 대한 일대일 교육을 시행하였고 환자의 만족도 및 복약순응도, 혈중 요산치의 변화 정도를 측정하였다. 교육을 받은 환자군의 진료만족도는 대조군에 비해 유의하게 높았으며 두 번째와 세 번째 외래 방문 시에 측정한 복약순응도와 혈중 요산치는 대조군에 비해 교육군에서 유의하게 개선이 되었다. 결론적으로 간호사 주도 환자교육은 진료 만족도 개선 및 질환 경과의 호전에도 도움이 되는 것으로 확인되었다.

Keywords

References

  1. P. Richette et al. (2014). Improving cardiovascular and renal outcomes in gout: what should we target?. Nature reviews. Rheumatology, 10(11), 654-661. DOI : 10.1038/nrrheum.2014.124
  2. D. I. Feig, D. H. Kang & R. J. Johnson. (2008). Uric acid and cardiovascular risk. The New England journal of medicine, 359(17), 1811-1821. DOI : 10.1056/NEJMra0800885
  3. R. D. Abbott, F. N. Brand, W. B. Kannel & W. P. Castelli. (1988). Gout and coronary heart disease: the Framingham Study. Journal of clinical epidemiology, 41(3), 237-242. DOI : 10.1016/0895-4356(88)90127-8
  4. E. Krishnan, J. F. Baker, D. E. Furst & H. R. Schumacher. (2006). Gout and the risk of acute myocardial infarction. Arthritis and rheumatism, 54(8), 2688-2696. DOI : 10.1002/art.22014
  5. H. K. Choi & G. Curhan. (2007). Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116(8), 894-900. DOI : 10.1161/CIRCULATIONAHA.107.703389
  6. M. A. De Vera, M. M. Rahman, V. Bhole, J. A. Kopec & H. K. Choi. (2010). Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Annals of the rheumatic diseases, 69(6), 1162-1164. DOI : 10.1136/ard.2009.122770
  7. J. F. Baker, H. R. Schumacher & E. Krishnan. (2007). Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology, 58(4), 450-457. DOI : 10.1177/0003319707303444
  8. E. Krishnan (2012). Gout and the risk for incident heart failure and systolic dysfunction. BMJ open, 2(1), e000282. DOI : 10.1136/bmjopen-2011-000282
  9. O. O. Seminog & M. J. Goldacre. (2013). Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology(Oxford,England), 52(12), 2251-2259. DOI : 10.1093/rheumatology/ket293
  10. K. Lottmann, X. Chen & P. K. Schadlich. (2012). Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Current rheumatology reports, 14(2), 195-203. DOI : 10.1007/s11926-011-0234-2
  11. G. G. Teng, L. W. Ang, K. G. Saag, M. C. Yu, J. M. Yuan & W. P. Koh. (2012). Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Annals of the rheumatic diseases, 71(6), 924-928. DOI : 10.1136/ard.2011.200523
  12. F. Perez-Ruiz, L. Martinez-Indart, L. Carmona, A. M. Herrero-Beites, J. I. Pijoan & E. Krishnan. (2014). Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Annals of the rheumatic diseases, 73(1), 177-182. DOI : 10.1136/annrheumdis-2012-202421
  13. L. Grimaldi-Bensouda et al. (2015). Impact of allopurinol on risk of myocardial infarction. Annals of the rheumatic diseases, 74(5), 836-842. DOI : 10.1136/annrheumdis-2012-202972
  14. J. H. Chen et al. (2015). Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study. The Journal of rheumatology, 42(9), 1694-1701. DOI : 10.3899/jrheum.141542
  15. F. Perez-Ruiz & G. Desideri. (2018). Improving adherence to gout therapy: an expert review. Therapeutics and clinical risk management, 14, 793-802. DOI : 10.2147/TCRM.S162956
  16. C. F. Kuo, M. J. Grainge, C. Mallen, W. Zhang & M. Doherty. (2015). Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Annals of the rheumatic diseases, 74(4), 661-667. DOI : 10.1136/annrheumdis-2013-204463
  17. B. McGowan, K. Bennett, C. Silke & B. Whelan. (2016). Adherence and persistence to urate-lowering therapies in the Irish setting. Clinical rheumatology, 35(3), 715-721. DOI : 10.1007/s10067-014-2823-8
  18. G. Zandman-Goddard, H. Amital, N. Shamrayevsky, R. Raz, V. Shalev & G. Chodick. (2013). Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford,England), 52(6), 1126-1131. DOI : 10.1093/rheumatology/kes431
  19. S. Mantarro, et al. (2015). Allopurinol adherence among patients with gout: an Italian general practice database study. International journal of clinical practice, 69(7), 757-765. DOI : 10.1111/ijcp.12604
  20. M. Dehlin, E. H. Ekstrom, M. Petzold, U. Stromberg, G. Telg & L. T. Jacobsson. (2017). Factors associated with initiation and persistence of urate-lowering therapy. Arthritis research & therapy, 19(1), 6. DOI : 10.1186/s13075-016-1211-y
  21. P. Richette et al. (2017). 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the rheumatic diseases, 76(1), 29-42. DOI : 10.1136/annrheumdis-2016-209707
  22. P. Richette, R. N. Flipo & D. K. Patrikos. (2015). Characteristics and management of gout patients in Europe: data from a large cohort of patients. European review for medical and pharmacological sciences, 19(4), 630-639.
  23. M. Hui et al. (2017). The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford,England), 56(7), 1056- 1059. DOI : 10.1093/rheumatology/kex150
  24. M. Doherty et al. (2018). Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet (London,England), 392(10156), 1403-1412. DOI : 10.1016/S0140-6736(18)32158-5
  25. C. H. Lee, H. S. Lim, Y. N. Kim, A. H. Park, E. C. Park & J. G. Kang (2014) Analysis of appropriate outpatient consultation time for clinical departments. Health Policy Management 24, 254-260. https://doi.org/10.4332/KJHPA.2014.24.3.254
  26. J. Hill. (1997). Patient satisfaction in a nurse-led rheumatology clinic. Journal of advanced nursing, 25(2), 347-354. DOI : 10.1046/j.1365-2648.1997.1997025347.x
  27. S. K. Cho et al. (2016). Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patients: A Randomized Trial of Nurse-led Versus Medical Docter-led Education. Journal of Rheumatic Diseases 23, 109-117. DOI : 10.4078/jrd.2016.23.2.109
  28. Y. I. Seo et al. (2011). Survey of Current Trends for Diagnosis and Treatment in Korean Gout Patients. Journal of Rheumatic Diseases. 18(3), 187-192. DOI : 10.4078/jrd.2011.18.3.187
  29. M. Doherty et al. (2012). Gout: why is this curable disease so seldom cured?. Annals of the rheumatic diseases, 71(11), 1765-1770. DOI : 10.1136/annrheumdis-2012-201687
  30. K. Spencer, A. Carr& M.Doherty. (2012). Patient and provider barriers to effective management of gout in general practice: a qualitative study. Annals of the rheumatic diseases, 71(9), 1490-1495. DOI : 10.1136/annrheumdis-2011-200801
  31. H. A. Zangi et al. (2015). EULAR recommendations for patient education for people with inflammatory arthritis. Annals of the rheumatic diseases, 74(6), 954-962. DOI : 10.1136/annrheumdis-2014-206807
  32. H. S. Koksvik, K. B. Hagen, E. Rodevand, P. Mowinckel, T. K. Kvien & H. A. Zangi. (2013). Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides. Annals of the rheumatic diseases, 72(6), 836-843. DOI : 10.1136/annrheumdis-2012-202296
  33. S. Ryan, A. Hassell, C. Thwaites, K. Manley & D. Home. (2007). Developing a new model of care for patients with chronic musculoskeletal pain. Journal of nursing management, 15(8), 825-829. DOI : 10.1111/j.1365-2934.2007.00761.x
  34. P. Makelainen, K. Vehvilainen-Julkunen & A. M. Pietila (2009). Rheumatoid arthritis patient education: RA patients' experience. Journal of clinical nursing, 18(14), 2058-2065. DOI : 10.1111/j.1365-2702.2008.02763.x
  35. C. E. Golin et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of general internal medicine, 17(10), 756-765. DOI : 10.1046/j.1525-1497.2002.11214.x
  36. Y. van Eijk-Hustings et al. (2012). EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Annals of the rheumatic diseases, 71(1), 13-19. DOI : 10.1136/annrheumdis-2011-200185
  37. N. Valentine, C. Darby & G. J. Bonsel (2008). Which aspects of non-clinical quality of care are most important? Results from WHO's general population surveys of "health systems responsiveness" in 41 countries. Socia lscience & medicine(1982), 66(9), 1939-1950. DOI : 10.1016/j.socscimed.2007.12.002